APA (7th ed.) Citation

Kong, X., Nguyen, N., Choi, Y., Zhang, G., Nguyen, H., Filka, E., . . . Lai, A. (2018). Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Elsevier Inc.

Chicago Style (17th ed.) Citation

Kong, X., et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Elsevier Inc, 2018.

MLA (9th ed.) Citation

Kong, X., et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Elsevier Inc, 2018.